Abingdon Health Plc (AIM:ABDX)
London · Delayed Price · Currency is GBP · Price in GBX 6.05
+0.15 (2.54%)
Oct 10, 2025, 3:26 PM GMT+1
Abingdon Health Market Cap
Abingdon Health has a market cap or net worth of 22.74 million as of October 10, 2025. Its market cap has decreased by -36.16% in one year.
Market Cap
22.74M
Enterprise Value
20.08M
Revenue
6.82M
Ranking
n/a
PE Ratio
n/a
Stock Price
6.05
Market Cap Chart
Since December 15, 2020, Abingdon Health's market cap has decreased from 100.96M to 22.74M, a decrease of -77.47%. That is a compound annual growth rate of -26.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 10, 2025 | 22.74M | -23.80% |
| Dec 31, 2024 | 29.85M | -10.74% |
| Dec 29, 2023 | 33.44M | 69.23% |
| Dec 30, 2022 | 19.76M | -80.30% |
| Dec 31, 2021 | 100.33M | 10.94% |
| Dec 31, 2020 | 90.44M | -10.43% |
| Dec 15, 2020 | 100.96M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 198.21B |
| GSK plc | 65.38B |
| Haleon | 30.16B |
| Smith & Nephew | 11.23B |
| ConvaTec Group | 4.78B |
| Hikma Pharmaceuticals | 4.02B |
| HUTCHMED (China) | 2.03B |
| Genus | 1.68B |